Research Articles | Page 2 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Nov 2020 Blood Advances Myelodysplastic Syndromes (MDS)
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes Mar 2019 Clin Lymphoma Myeloma Leuk Myelodysplastic Syndromes (MDS)
A stimulating advance in erythropoiesis for patients with myelodysplastic syndromes Sep 2024 Lancet Haematology Myelodysplastic Syndromes (MDS)
A stimulating advance in erythropoiesis for patients with myelodysplastic syndromes Jul 2024 Lancet Haematology Myelodysplastic Syndromes (MDS)
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort Aug 2020 Pediatric Blood & Cancer Aplastic Anemia, Pediatric
Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation Jun 2024 Journal of Hematology Aplastic Anemia
Activin Receptor II Ligand Traps: New Treatment Paradigm for Low-Risk MDS Jun 2019 Current Hematologic Malignancy Report Myelodysplastic Syndromes (MDS)
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Apr 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Advances in the management of higher-risk myelodysplastic syndromes: future prospects Sep 2024 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)